Senzime AB (publ) (SNZZF)
OTCMKTS · Delayed Price · Currency is USD
0.6500
0.00 (0.00%)
Oct 22, 2025, 8:00 PM EDT
Senzime AB Market Cap
Senzime AB has a market cap or net worth of $99.28 million as of October 24, 2025. Its market cap has increased by 27.79% in one year.
Market Cap
99.28M
Enterprise Value
86.79M
Revenue
8.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.65
Market Cap Chart
Since June 18, 2008, Senzime AB's market cap has increased from 5.90M to 99.28M, an increase of 1,582.66%. That is a compound annual growth rate of 17.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 99.28M | 50.49% |
| Dec 30, 2024 | 65.97M | -25.20% |
| Dec 29, 2023 | 88.19M | 22.48% |
| Dec 30, 2022 | 72.00M | -54.29% |
| Dec 30, 2021 | 157.52M | -13.94% |
| Dec 30, 2020 | 183.03M | 78.73% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 804.99M |
| Elite Pharmaceuticals | 644.08M |
| Glass House Brands | 624.73M |
| Silence Therapeutics | 349.53M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.41M |
| Northwest Biotherapeutics | 324.50M |
| American Oncology Network | 289.95M |